Angelman Syndrome (AS) Biomarker Study

NCT04103333 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Biogen